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• 5% of cancer patients and 8% of caregivers screened positively for alcohol use 
disorders on the AUDIT. 
• 6% of patients and 3% of caregivers screened positively for drug abuse on the DAST-
10. 
• Caregivers screening positively for drug and alcohol problems had significantly higher 
carer burden scores. 




More than 300 000 people are diagnosed with cancer annually in the United Kingdom. 
Half of those diagnosed will not survive the disease and are living with advanced cancer 
for a period of time (Cancer Research UK 2016). It is estimated that 8% of cancer deaths 
in men, and 3% in women, are attributable to excessive alcohol consumption (Schultz et 
al 2011, World Health Organisation 2007). However, it is less well known whether excess 
alcohol consumption continues to be, or starts to be, a problem during the course of the 
illness. Living with cancer, having burdensome treatments and facing the end of life have 
a significant emotional impact. It is well documented that rates of psychological illness 
are higher in people with cancer than the general population (Hotopf et al 2002, 
McManus et al 2007). However, it is unclear whether alcohol and drug use disorders co-
exist with these problems.  
 
There have been a number of retrospective studies assessing the prevalence of alcohol 
dependence in advanced cancer patients in North America and Europe (Parsons et al 
2008, Jenkins et al 1998, Jenkins et al 2000, Bruera et al 1995, Bruera et al 2000, 
Mercadenate et al 2015). This is reported as being 4-38% using the CAGE questionnaire 
and 18% using the Alcohol Use Disorders Identification Tool (AUDIT) (Webber and Davie 
2012). These results are difficult to interpret as the CAGE refers to lifetime use, not 
recent use, the datasets were small and retrospective and a number of included patients 
had missing data.  
 
Many people with advanced cancer are appropriately prescribed strong painkillers for 
their problems. However, there is limited published United Kingdom data assessing 
whether drug abuse exists in this population, either from prescribed opioids or other 
drugs. It is an important distinction to make in such patients to enable safe prescribing 
and enhancing quality of life. In the United States prevalence rates of drug abuse in 
cancer patients range from 3-19% however population level issues are considerably 
higher in the U.S. making it difficult to extrapolate (Derogatis et al 1983, Webber and 





Caregivers of advanced cancer patients suffer higher levels of distress and lower levels 
of well-being as compared to age-matched non-caregivers (Pinquart and Sorenson 2003, 
Grov et al 2005). Caregivers of patients with other chronic problems (head injury, 
dementia) have high levels of alcohol use disorders and these are related to worse health 
outcomes and coping (Bayen et al 2014, Gallant et al 1997). A prospective study from 
Europe assessed cancer caregivers using the CAGE questionnaire; eleven percent 
screened positively for alcohol dependence (Rumpold et al 2015)). They did not 
specifically assess the relationship between alcohol dependence and other psychiatric 
problems or caregiver burden and there was no assessment of drug abuse problems.  
 
There are few published studies that primarily assess the prevalence of alcohol and drug 
use disorders in both cancer patients and their caregivers. There are limited datasets 
evaluating the relationship between alcohol and drug abuse and carer burden, as well as 
the impact of the cancer patient’s behaviours and symptoms on carer burden.  
 
The aim of this study, supported by Alcohol Change UK, was to establish the prevalence 
of alcohol and drug use disorders in a large cohort of advanced cancer patients and their 
caregivers. Secondary aims were to evaluate the relationship between these problems 
and symptoms and carer burden. An overarching purpose of the study is to establish a 




This study recruited cancer patients across eleven United Kingdom sites. Five centres 
were National Health Service Hospitals and six sites were independent hospices.  
 
Patients were recruited from hospital inpatient and outpatient departments, and hospice 
inpatient units and community services. Patients aged >18 years with a diagnosis of 
advanced cancer and their primary caregiver, as identified by the patient, were 
approached. Patients without a caregiver were excluded.  
 
This study has U.K. Research Ethics Committee approval (IRAS 198753). All participants 




Patient and caregiver demographic data were collected at interview. Details about 
prescribed painkillers and diagnosis were gathered by interview and also chart review. 




The patient completed the following measures: 
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• Alcohol Use Disorders Identification Test. A validated questionnaire to screen for the 
presence of alcohol misuse in the last 12 months. A cut off score of 8 was used to 
categorise alcohol misuse (Babor et al 2001). 
• CAGE questionnaire (Mayfield, McLeod and Hall 1974). Four questions about lifetime 
alcohol consumption. A cut off score of 2 or more positive answers was used to 
determine alcohol dependence.  
• Memorial Symptom Assessment Scale-Short Form (MSAS-SF). A 32-item validated 
questionnaire assessing physical and psychological symptoms. (Chang et al 2000) 
• The data will be presented using the three subscales, global distress index (GDI), 
physical subscale (PHYS) and psychological subscale (PSYCH). PSYCH has been 
validated to detect anxiety and depressive disorders (Webber and Davies 2011) 
• Drug abuse screening test (DAST 10). A validated ten item questionnaire to assess for 
drugs abuse over the previous 12 months (Yudko et al 2007). A cut-off score of 2 
was used to determine drug abuse.  
 
The caregiver completed the following: 
 
• Alcohol Use Disorders Identification Test.  
• CAGE questionnaire 
• Drug abuse screening test (DAST-10).  
• Zarit burden inventory (ZBI).  A validated 29 item scale designed to measure feelings 
of burden experienced by caregivers of medically ill persons. A cut off score of 21 
was used to determine significant carer burden. (Zarit, Reever and Back-Peterson 
1980) 
 
Statistical analysis  
   
A sample size of 500 patients was calculated to estimate the prevalence of alcohol use 
disorders according to the AUDIT with a two-sided 95% confidence interval; according to 
expected proportion 18% +/- 3.3%).  
 
Patient and caregivers were categorised into cases and non-cases of alcohol use 
disorders (AUDIT scale), alcohol dependence (CAGE) and drug abuse (DAST-10) to 
determine the prevalence of each. These different groups were compared with 
continuous variable data to establish the relationship between alcohol and drug misuse 
and the patient’s physical and psychological symptoms (MSAS-SF) and carer burden 
(Zarit). A comparison was also made between the patient’s symptom scales and carer 
burden. Comparisons between categorical and continuous variables was made using the 







Patient and caregiver characteristics 
 
A total of five hundred and seven patients and their caregivers were recruited over eleven 
United Kingdom sites (744 approached, 237 declined to enter). Forty-eight percent were 
recruited from hospital sites and fifty two percent from hospices.  
 
The median age of patients was 68 and their caregivers was 66. Fifty four percent of 
patients were male. The majority of caregivers were spouses or partners. Two hundred 
and thirteen carers (42%) experienced significant carer burden as defined by the Zarit 
Burden Inventory (ZBI).  
 
Patient and caregiver prevalence rates of alcohol and drug misuse 
 
Twenty-seven patients (5%) and forty-four caregivers (8%) screened positively for 
alcohol use disorders on the AUDIT. In eight cases both the patient and caregiver 
screened positively.  
 
Fifty-seven patients (11%) and forty-eight caregivers (9%) screened positively for lifetime 
alcohol dependence using the CAGE questionnaire.   
 
Eighty five percent (85%) of patients, and twenty seven percent (27%) of carers, were 
taking regular painkillers. The majority of painkillers were prescribed opioids. Thirty 
patients (6%), and sixteen caregivers (3%), screened positively for drug abuse problems 
on the DAST-10.  
 
Factors associated with a high carer burden 
 
There was a significantly higher caregiver burden score in caregivers screening positively 
for alcohol and drug abuse problems on the AUDIT, CAGE and DAST-10.  
 
A higher burden was also experienced by caregivers if patients had worse physical and 
psychological symptoms.  
 
Caregiver burden was not affected by the patient’s drug or alcohol abuse issues.  
 
Relationship between alcohol and drug abuse and patient’s symptoms 
 
Patients with AUDIT defined alcohol problems had lower global distress index (MSAS-
GDI) and physical symptom scores (MSAS-PHYS) than those without. There was no 
difference in psychological symptoms (MSAS-PSYCH) between groups.  
 
There was no difference in physical or psychological symptoms between patients 






The prevalence of cancer patients’ alcohol use disorders and dependence was lower 
than reported in previous studies. Only 5% of patients had harmful levels of alcohol use 
disorders in the previous year (AUDIT positive) with a higher number having a positive 
CAGE (11%). The CAGE questionnaire assessed lifetime dependence rather than 
current issues suggesting a proportion of patients had previously had problems but 
weren’t currently using alcohol harmfully (Mayfield, McLeod and Hall 1974).  
 
The level of current alcohol use disorders in patients and caregivers is lower than the 
general population for this age range taking into account sex differences (NHS Digital 
Survey 2014).  However, lifetime alcohol dependence rates (CAGE) are higher than 
equivalent general population for both patients and caregivers (NHS Digital Survey 
2014). This suggests that individuals with previous issues do not necessarily have 
current patterns of misuse but must be evaluated carefully and non-judgementally.  
 
Eighty-five percent of patients were taking prescribed painkillers and six percent 
screened positively for drug abuse. This is the first estimated prevalence rate of drug 
abuse in cancer patients in the United Kingdom and is higher than general population 
levels accounting for age (aged 55+ drug abuse rates are less than 1%) (NHS Digital 
Survey 2014). This indicates that drug abuse is an issue that should be assessed when 
prescribing painkillers for all cancer patients.  
 
Studies from the United States report a prevalence rate of 3-19% for drug abuse in 
cancer patients however this coincides with a much higher general population rate for the 
same age group (Derogatis et al 1983, Webber and Haber 2008 and Yennurajalingam et 
al 2018). 
 
Twenty-seven percent of caregivers were taking prescribed painkillers. This is higher 
than United Kingdom general population data and indicates that caregivers have 
significant health care needs and morbidity of their own (Office of National Statistics 
2018). Whilst this study did not look in detail at this issue it supports published data about 
the physical and psychological health problems prevalent in caregivers (Office of National 
Statistics 2018). Three percent of caregivers screened positively for drug abuse problems 
which is higher than general population rates for this age group (NHS Digital Survey 
2014). In one-third of cases both patient and caregiver screened positively suggesting 
this is an issue that must be assessed in both cases. There is no published analogous 
data for the caregivers of cancer patients and it raises important issues about prescribing 
and screening of this group. Concurrent alcohol and drug abuse problems co-existed in 
only three patients and three caregivers. 
 
There was a significantly higher carer burden score associated with caregiver alcohol 
and drug use disorders and lifetime alcohol dependence. It is not known whether this is 
cause or effect. A previous European study did not identify a positive CAGE 




A higher carer burden was also associated with patient’s physical and psychological 
symptom burden. The causes of caregiver burden are complex but the literature reports a 
stronger association between burden and patient’s physical care needs, social networks 
and information needs than symptoms (Hsu et al 2017,Hsu et al 2014). There has been 
no previous reported association between Zarit burden score and symptoms reported on 




There were limitations to this study. Firstly, the methods used to define alcohol and drug 
use disorders and lifetime alcohol dependence were screening tools. They are indicative 
of problems but a structured clinical interview would be used in practice to diagnose 
these issues. Secondly, the prevalence rates were low and the study was not powered to 
detect differences between groups. Despite this the fact that differences were seen 
reveals a powerful link between data described above. There were a considerable 
number of people who declined to take part in the study. This was predominantly due to 
fatigue and caregiver not being present during working hours. However, it is possible that 
people with alcohol and drug use disorders were more reluctant to take part thus 
underestimating the prevalence. Lastly, the study took place in the United Kingdom and 
despite using multiple sites conclusions may not be able to be extrapolated to other 




The association of alcohol and drug use disorders with carer burden indicates the 
importance of screening and supporting caregivers of cancer patients. An individualised 
needs assessment is recommended to identify issues and implement support strategies. 
All patients started on strong painkillers should be monitored for drug misuse especially 
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